Carl Anthony Evans - 08 Apr 2024 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
08 Apr 2024
Net transactions value
$0
Form type
4
Filing time
10 Apr 2024, 21:52:02 UTC
Previous filing
06 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNSP Option to purchase common stock Award +17,500 +16% 129,594 08 Apr 2024 Common Stock 17,500 $0.2586 Direct F1, F2
transaction CNSP Restricted Stock Units Award +17,500 +14% 147,094 08 Apr 2024 Common Stock 17,500 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
F2 The awards were issued in connection with the reporting person's Board of Director services to the Company.
F3 Each restricted stock unit represents a contingent right to receive one share of the Company common stock.